Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 8/22/2025NMPA Approves Domestic Hexavalent Rotavirus Vaccine for Children
  • 8/22/2025CARsgen's Satri-cel Becomes First CAR-T Therapy for Solid Tumors to Re...
  • 8/22/2025Kintor's KX-826 Tincture Nabs Triumph in Phase II Male AGA Trial
  • 8/21/2025Anixa Secures First Chinese Patent for Breast Cancer Vaccine Technolog...
  • 8/21/2025Zelgen Secures FDA IND Approval for Novel Trispecific Cancer Therapy
  • 8/21/2025Novartis' Vanrafia (atrasentan) Gains Regulatory Nod in China as Secon...
  • 8/21/2025Nicox Targets U.S. and China Filings After Second Phase III Win for NC...
  • 8/20/2025Pfizer Advances Pneumococcal Vaccine Development in China with Phase 1...
  • 8/19/2025Onconic's GERD Drug Jaqbo Advances in China Following Phase 3 Success
  • 8/19/2025CSPC Pharma Advances in Biosimilars with Dupilumab Injection Approval
  • 8/19/2025Innovent Presents Phase 2 Study of Tarlatamab in Third-Line ES-SCLC at...
  • 8/19/2025BioNTech's BNT327 Shows Strong Phase II Results as China-Originated Dr...
  • 8/14/2025Remegen's Telitacicept Achieves Phase III Success
  • 8/14/2025CTTQ Unveils Promising Phase 2 Data for HER2 Bispecific ADC TQB2102
  • 8/14/2025GenFleet's GFH375 KRAS G12D Inhibitor Delivers Strong NSCLC Data
  • 8/14/2025Qihan Earns FDA Green Light for Pioneering Dual-Target CAR-T Therapy i...
  • 8/14/2025Innovent's U.S. Unit Fortvita Launches Phase 1 Trial of Oral GLP-1 Ago...
  • 8/14/2025ArkBio's Ziresovir Included into Pediatric RSV Drug Priority List by W...
  • 8/13/2025Gracell Gains NMPA Approval to Advance GC012F into Light-Chain Amyloid...
  • 8/13/2025CTTQ Secures IND Acceptance from China's NMPA for Two Innovative Cance...
  • 8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...
  • 8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab
  • 8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC
  • 8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China
  • 8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...
  • 8/8/2025AstraZeneca Expands Use of Fasenra in China
  • 8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...
  • 8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...
  • 8/6/2025Everest's Nefecon Won NMPA Approval for Poduction Expansion to Meet Ri...
  • 8/6/2025Global Pharma Bets on China's AI Biotech for Next-Gen Drug Discovery
  • Page:12/22 Total number of articles:647: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group